Revance Therapeutics Inc (RVNC)
3.025
-0.14
(-4.27%)
USD |
NASDAQ |
May 17, 16:00
3.02
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics 1 Year Total Returns (Daily): -90.54% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -90.54% |
| May 16, 2024 | -90.56% |
| May 15, 2024 | -90.22% |
| May 14, 2024 | -90.11% |
| May 13, 2024 | -90.56% |
| May 10, 2024 | -90.83% |
| May 09, 2024 | -88.59% |
| May 08, 2024 | -88.33% |
| May 07, 2024 | -87.34% |
| May 06, 2024 | -88.15% |
| May 03, 2024 | -88.25% |
| May 02, 2024 | -88.62% |
| May 01, 2024 | -88.25% |
| April 30, 2024 | -88.66% |
| April 29, 2024 | -88.41% |
| April 26, 2024 | -89.21% |
| April 25, 2024 | -89.60% |
| April 24, 2024 | -88.67% |
| April 23, 2024 | -88.60% |
| April 22, 2024 | -88.66% |
| April 19, 2024 | -88.04% |
| April 18, 2024 | -87.59% |
| April 17, 2024 | -87.47% |
| April 16, 2024 | -87.47% |
| April 15, 2024 | -86.95% |
| Date | Value |
|---|---|
| April 12, 2024 | -86.47% |
| April 11, 2024 | -85.86% |
| April 10, 2024 | -85.99% |
| April 09, 2024 | -86.22% |
| April 08, 2024 | -86.92% |
| April 05, 2024 | -86.66% |
| April 04, 2024 | -86.80% |
| April 03, 2024 | -86.53% |
| April 02, 2024 | -86.00% |
| April 01, 2024 | -85.32% |
| March 28, 2024 | -84.33% |
| March 27, 2024 | -84.89% |
| March 26, 2024 | -85.17% |
| March 25, 2024 | -85.33% |
| March 22, 2024 | -84.68% |
| March 21, 2024 | -84.17% |
| March 20, 2024 | -84.28% |
| March 19, 2024 | -84.66% |
| March 18, 2024 | -84.62% |
| March 15, 2024 | -82.69% |
| March 14, 2024 | -81.59% |
| March 13, 2024 | -78.85% |
| March 12, 2024 | -78.05% |
| March 11, 2024 | -78.13% |
| March 08, 2024 | -81.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.83%
Minimum
May 10 2024
184.3%
Maximum
Aug 28 2020
8.40%
Average
-2.38%
Median
Sep 10 2021
1 Year Total Returns (Daily) Benchmarks
| AbbVie Inc | 20.83% |
| Eli Lilly and Co | 77.30% |
| Aquestive Therapeutics Inc | 51.71% |
| Humacyte Inc | 52.90% |
| AN2 Therapeutics Inc | -72.58% |